The Korean Journal of Medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지
DOI QR코드

DOI QR Code

Peritoneal Dialysis-associated Peritonitis Caused by Chryseobacterium indologenes

Chryseobacterium indologenes에 의해 발생한 복막투석 관련 복막염 1예

  • Choi, Myung Woo (Division of Nephrology, Department of Internal Medicine, Presbyterian Medical Center) ;
  • Oh, Sung Sik (Division of Nephrology, Department of Internal Medicine, Presbyterian Medical Center) ;
  • Choi, Mi Rim (Division of Nephrology, Department of Internal Medicine, Presbyterian Medical Center) ;
  • Lee, Jong Hwa (Division of Nephrology, Department of Internal Medicine, Presbyterian Medical Center) ;
  • Yang, Hyun Ju (Division of Nephrology, Department of Internal Medicine, Presbyterian Medical Center) ;
  • Sun, In O (Division of Nephrology, Department of Internal Medicine, Presbyterian Medical Center) ;
  • Lee, Kwang Young (Division of Nephrology, Department of Internal Medicine, Presbyterian Medical Center)
  • Received : 2015.11.30
  • Accepted : 2016.05.25
  • Published : 2018.02.01
⟨ Previous Next ⟩

Abstract

Chryseobacterium indologenes (C. indologenes) is a nonmotile, gram-negative bacillus that is widely distributed in nature. Generally considered nonpathogenic, C. indologenes rarely infects humans and is not normally present in the human microflora. C. indologenes infections have been observed in cases of peritoneal dialysis (PD)-associated peritonitis, although the incidence of these infections is low. Although C. indologenes is generally susceptible to trimethoprim-sulfamethoxazole, levofloxacin, ciprofloxacin, piperacillin-tazobactam, and cefepime, no guidelines have been established for the treatment of PD-associated peritonitis. Here we report the first case of PD-associated peritonitis in Korea with C. indologenes identified as the sole etiologic agent. The patient recovered after intraperitoneal antibiotic treatment without the need for Tenckhoff catheter removal.

Keywords

References

  1. Troidle L, Gorban-Brennan N, Kliger A, Finkelstein FO. Continuous peritoneal dialysis-associated peritonitis: a review and current concepts. Semin Dial 2003;16:428-437. https://doi.org/10.1046/j.1525-139X.2003.16095.x
  2. Afshar M, Nobakht E, Lew SQ. Chryseobacterium indologenes peritonitis in peritoneal dialysis. BMJ Case Rep 2013;2013:bcr2013009410.
  3. Hsueh PR, Hsiue TR, Wu JJ, et al. Flavobacterium indologenes bacteremia: clinical and microbiological characteristics. Clin Infect Dis 1996;23:550-555. https://doi.org/10.1093/clinids/23.3.550
  4. Lin YT, Jeng YY, Lin ML, Yu KW, Wang FD, Liu CY. Clinical and microbiological characteristics of Chryseobacterium indologenes bacteremia. J MicrobiolImmunol Infect 2010;43:498-505.
  5. Vandamme P, Bernardet JF, Segers P, Kersters K, Holmes B. New perspectives in the classification of the flavobacteria: description of Chryseobacterium gen. nov., Bergeyella gen. nov., and Empedobacternom. rev. Int J Syst Bacteriol 1994;44:827-831. https://doi.org/10.1099/00207713-44-4-827
  6. Hsueh PR, Teng LJ, Yang PC, Ho SW, Hsieh WC, Luh KT. Increasing incidence of nosocomial Chryseobacterium indologenes infections in Taiwan. Eur J Clin Microbiol Infect Dis 1997;16:568-574. https://doi.org/10.1007/BF02447918
  7. Yoon JS, Hwang EA, Chang MH, et al. Peritonitis by Chryseobacterium indologenes and Sphingomonaspaucimobilis in a patient undergoing continuous ambulatory peritoneal dialysis (CAPD). Korean J Nephrol 2007;26:801-805.
  8. Li PK, Szeto CC, Piraino B, et al. Peritoneal dialysis-related infections recommendations: 2010 update. Perit Dial Int 2010;30:393-423. https://doi.org/10.3747/pdi.2010.00049
  9. Kirby JT, Sader HS, Walsh TR, Jones RN. Antimicrobial susceptibility and epidemiology of a worldwide collection of Chryseobacteriumspp: report from the SENTRY Antimicrobial Surveillance Program (1997-2001). J Clin Microbiol 2004;42:445-448. https://doi.org/10.1128/JCM.42.1.445-448.2004

Cited by

  1. Chryseobacterium indologenesperitonitis in a peritoneal dialysis patient vol.11, pp.1, 2018, https://doi.org/10.1136/bcr-2018-227713